NutriBand (NTRB) Debt to Equity (2016 - 2026)

NutriBand's (NTRB) quarterly Debt to Equity came in at $0.0 in Q1 2026, down 47.52% year-on-year from $0.01 in Q1 2025, and down 13.79% quarter-over-quarter from $0.01 in Q4 2025.

NutriBand (NTRB) Debt to Equity (2016 - 2026) Analysis & Trends

NutriBand has disclosed Debt to Equity across 11 years of filings, most recently posting $0.0 for Q1 2026.

  • Debt to Equity for Q1 2026 came in at $0.0, down 47.52% year-over-year; the trailing twelve-month figure through Jan 2026 was $0.0 (down 47.52% YoY), and the FY2026 annual result was $0.0, down 47.52% from the prior year.
  • Debt to Equity came in at $0.0 for Q1 2026 at NutriBand, down from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.01 in Q4 2023 to a low of $0.0 in Q1 2026.
  • The 5-year median for Debt to Equity is $0.01 (2025), against an average of $0.01.
  • Across the five-year window, Debt to Equity plunged 61.93% in 2024 and surged 84.97% in 2025, its largest moves.
  • NutriBand's Debt to Equity stood at $0.01 in 2022, then surged by 37.43% to $0.01 in 2023, then slumped by 61.93% to $0.01 in 2024, then declined by 2.85% to $0.01 in 2025, then dropped by 13.79% to $0.0 in 2026.
  • The last three Debt to Equity figures came in at $0.0 (Q1 2026), $0.01 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 NutriBand 41.91 Mn 37.33 Mn 88,941.00 0.00

Historic Data

Download Data
DateValue
Jan 31, 2026 0.00
Oct 31, 2025 0.01
Jul 31, 2025 0.01
Apr 30, 2025 0.01
Jan 31, 2025 0.01
Oct 31, 2024 0.01
Jul 31, 2024 0.01
Apr 30, 2024 0.01
Jan 31, 2024 0.01
Oct 31, 2023 0.01
Jul 31, 2023 0.01
Apr 30, 2023 0.01
Jan 31, 2023 0.01
Oct 31, 2022 0.01
Jul 31, 2022 0.01
Apr 30, 2022 0.01
Jan 31, 2022 0.01
Oct 31, 2021 0.01
Jul 31, 2021 0.01
Apr 30, 2021 0.01